Lavery Publications and Research


Dr. Lavery is currently Director, Ph.D. Program in Global Health and Development, Hubert Department of Global Health, Rollins School of Public Health. He is currently focused on research to understand the role of “equity” in decision-making for global vaccine procurement and distribution in order to develop improved practices for prioritization and ethical reasoning in vaccine discovery, development and delivery. He is also working to convene global stakeholders to deliberate on opportunities for cooperation, integration, and innovation to improve child survival rates in partnership with experts in anti-microbial resistance.

Jim Lavery's Full CV

Google Scholar Citations

Publications 2020-current

In Press

Wodnik BK, Buesseler H, Chatterjee D, Keronyai PP, Kawooya P, Namuswe D, Tumusiime J, Omar U, Musulwa A, Obbuyi A, Wanjeri V,  Addiss D, Lavery JV, Di Ruggiero E. Organizational features associated with compassion in two primary healthcare centres in Kenya and Uganda. International Journal of Wellbeing 2026 [In Press]

Lavery JV, Meslin EM, Singer PA, Upshur REG. Is it time to disrupt the global research ethics paradigm? [Invited contribution to the Festschrift honouring Prof. Solomon Benatar]. South African Medical Journal 2026 [In Press]

Published

Grek M, Graham AL, Addiss DG, Lavery JV. What ethical issues arise in global health programmes? A qualitative case study of global health programme leaders’ experiences. BMJ Open 2025; 15:e096456. doi:10.1136/ bmjopen-2024-096456

Dickert NW, Spiegelman D, Blumenthal-Barby JS, Graham G, Joffe S, Kahn JM, Kass NE, Kim SYH, Kerlin MP, Langford AT, Lavery JV, Matlock DD, Fenton KN, Mensah GA. Ethical issues in implementation science: perspectives from a National Heart, Lung, and Blood Institute workshop. Implementation Science 2024; 19(1): 77-85.

Wodnik BK, Andiappan M, Di Ruggiero EMC, Lavery JV. An expanded 4I framework to conceptualize inter-organizational learning in the global health sector. BMJ Open 2024; 0:e083830. doi:10.1136/ bmjopen-2023-083830

Vincent R, Kamuya D, Adhikari B, Nyirenda D, Lavery JV, Molyneux S. Community engagement and the centrality of ‘working relationships’ in health research. BMJ Global Health 2024;9:e015350. doi:10.1136/ bmjgh-2024-015350

Schuh HB, Rimal RN, BReiman RF, Orton PZ, Dudley MZ, Kao LS, Sargent RH Laurie S, Weakland LF, Lavery JV, Orenstein WA, Brewer J, Jamison AM, Shaw J, Willock RJ, Gust D, Salmon DA. Evaluation of online videos to engage viewers and support decision-making for COVID-19 vaccination: how narratives and race/ethnicity enhance viewer experiences. Frontiers in Public Health 2023; Volume 11 - 2023 | https://doi.org/10.3389/fpubh.2023.1192676

Lavery JV, Porter RM, Addiss DG. Cascading failures in COVID-19 vaccine equity. Science 2023; 380(6644): 460-462. DOI: 10.1126/science.add5912

Horn L, Alba S, Gopalakrishna G, Kleinert S, Kombe F, Lavery JV, Viagie RG. The Cape Town Statement on fairness, equity and diversity in research. Nature 2023; 615: 790-793. doi:https://doi.org/10.1038/d41586-023-00855-y

Salmon DA, Schuh H, Sargent R, Konja A, Harvey S, Laurie S, Brandy M, Weakland L, Lavery JV, Orenstein W, Breiman R. Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population. PLoS ONE 2022; 17(10): e0274443. https://doi.org/10.1371/journal.pone.0274443

Taitingfong RI, Triplett C, Vásquez VN, Rajagopalan R, Raban R, Roberts A, Terradas G, Baumgartner B, Emerson C, Gould F, Okumu F, Schairer CE, Bossin H, Buchman L, Campbell KJ, Clark A, Delborne J, Esvelt K, Fisher J, Friedman RM, Gronvall G, Gurfield N, Heitman E, Kofler N, Kuiken T, Kuzma J, Manrique-Saide P, Marshall J, Montague M, Morrison A, Opesen CC, Phelan R, Piaggio A, Quemada H, Rudenko L, Sawadogo N, Smith R, Tuten H, Ullah A, Vorsino A, Windbichler N, Akbari O, Long K, Lavery JV, Evans SW, Tountas K, Bloss CS. Exploring the Value of a Global Gene Drive Project Registry. Exploring the value of a gene drive project registry. Nature Biotechnology December 15, 2022. https://doi.org/10.1038/s41587-022-01591-w

Sargent RH, Laurie S, Weakland LF, Lavery JV, Salmon DA, Orenstein WA, Breiman RF. Use of Random Domain Intercept Technology to Track COVID-19 Vaccination Rates in Real-Time Across the United States: Survey Study. Journal of Medical Internet Research—Public Health and Surveillance 2022; 24(7): https://www.jmir.org/2022/7/e37920

Horn L, Alba S, Blom F, Faure M, Flack-Davison E, Gopalakrishna G, IJsselmuiden C, Labib K, Lavery JV, Masekela R, Schroeder D, Simon N, Van Zyl C, Vasconcelos S, Visagie R, Kombe F. Fostering research integrity through the promotion of fairness, equity and diversity in research collaborations and contexts: Towards a Cape Town Statement (pre-conference discussion paper for the 7th World Conference on Research Integrity, Cape Town, South Africa). OSFPreprints 2022; https://osf.io/bf286

Sargent RH, Laurie S, Moncada L, Weakland LF, Lavery JV, Salmon DA, Orenstein WA, Breiman RF. Masks, money and mandates: A national survey of efforts to increase vaccination intentions in the United States. PLOS ONE 2022; 17(4): 0267154. https://doi.org/10.1371/journal.pone.0267154

Vincent R, Adhikari B, Duddy C, Richardson E, Wong G, Lavery JV, Molyneux S. ‘Working relationships’ across difference—a realist review of community engagement with malaria research. Wellcome Open Research 2022; Jan 13, 2022. https://doi.org/10.12688/wellcomeopenres.17192.1

Shah SK, London AJ, Mofenson L, Lavery JV, John-Stewart G, Flynn P, Theron G, Bangdiwala S, Moodley D, Chinula L, Fairlie L, Sekoto T, Kakhu TJ, Violari A, Dadabhai S, McCarthy K, Fowler MG. Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial. Clinical Trials 2021 Sep 15;17407745211045734. doi: 10.1177/17407745211045734.

IJsselmuiden C, Ntoumi F, Lavery JV, Montoya J, Karim SA, Kaiser K. Should global financing be the main priority for pandemic preparedness? (Correspondence). Lancet 2021; 398(10298): 388. doi: 10.1016/S0140-6736(21)01387-8.

Shadab R, Lavery JV, Elharake JA, Malik F, Omer SB. Key ethical considerations to guide the adjudication of a single-dose HPV vaccine schedule. Human Vaccines & Immunotherapeutics 2021; DOI: 10.1080/21645515.2021.1917231

Addiss DG, Kienast Y, Lavery JV. Ethical dimensions of neglected tropical disease programming. Transactions of the Royal Society of Tropical Medicine & Hygiene 2021; 115: 190-195

Long​ KC, Alphey​ L, Bloss​ CS, Campbell​ KJ, Champer​ J, Chen​ CH, Choudhary​ A, Church​ GM, Collins​ JP, Cooper​ KL, Delborne​ JA, Edwards​ OR, Emerson​ CI, Esvelt​ K, Evans​ SW, Friedman​ RM, Gantz​ VM, Gould​ F, Hartley​ S, Heitman​ E, Hemingway​ J, Kanuka​ H, Kuzma​ J, Lavery JV, Lee​ Y, Lunshof JE,​ Marshall​ JM, Messer​ PW, Montell​ C, Oye​ KA, Palmer​ MJ, Papathanos​ PA, Paradkar​ PN, Piaggio​ AJ, Rasgon​ JL, Rašić G, Rudenko​ L, Saah​ JR, Scott​ MJ, Snow​ AA, Sutton​ JT, Vorsino​ AE, Akbari OS.​ Core commitments for field trials of gene-drive organisms. Science 2020; 370(6523): 1417-19.

Valdez D, Keys H, Ureña K, Cabral D, Camilo F, Ogando EC, Mercedes L, Noland GS, Blount SB, Lavery JV, Desir L, Puello J. Malaria outbreak response in urban Santo Domingo, Dominican Republic: lessons learned for community engagement. Pan American Journal of Public Health 2020; 44: https://doi.org/10.26633/RPSP.2020.92 1

Wodnik BK, Louis DH, Joseph M, Wilkers LT, Landskroener SD, Desir L,Lemoine JF, Lavery JV. The Roles of Stakeholder Experience and Organizational Learning in Declining Mass Drug Administration Coverage for Lymphatic Filariasis in Port-au-Prince, Haiti: A Case Study. PLoS Neglected Tropical Diseases 2020; 14(5): e0008318. (https://doi.org/10.1371/journal. pntd.0008318)

Richardson EZL, Bandewar SVS, Boulanger RF, Mehta R, Lin T, Vincent R, Molyneux S, Lavery JV. Addressing diversity and complexity in the community engagement literature: The rationale for a realist review. Gates Open Research 2020; 5:1 (https://doi.org/10.12688/wellcomeopenres.15525.1)

Billingsley P, Binka F, Chaccour C, Foy B, Gold S, Gonzalez-Silva M, Jacobson J, Jagoe G, Jones C, Kachur P, Kobylinkski K, Last A, Lavery JV, Mabey D, Mboera L, Mbogo C, Rabinovich NR, Rees S, Richards F, Rist C, Rockwood J, Ruiz-Castillo P, Sattabongkot J, Saute F, Slater H, Steer A, Xia K, Zulliger R (the Ivermectin Roadmappers). A roadmap for the development of Ivermectin as a complementary malaria vector control tool. American Journal of Tropical Medicine & Hygiene 2020; January 22, 2020: 1–22. doi:10.4269/ajtmh.19-0620

Boulanger RF, García-García L, Ferreyra-Reyes L, Canizales-Quintero S, Palacios-Martínez M, Ponce-de-Leon A, Lavery JV. Integrating tuberculosis research with public health infrastructure: Lessons for community engagement from Orizaba, Mexico. Gates Open Research 2020; 4:11 (https://doi.org/10.12688/gatesopenres.13058.1)